Clover Health Investments, Corp.
CLOV
$2.69
$0.020.75%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -242.79% | 93.35% | 68.65% | 77.92% | 125.71% |
Total Depreciation and Amortization | 19.39% | 46.54% | -48.96% | -39.14% | -66.97% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -2.87% | 30.97% | 89.07% | -40.16% | -22.00% |
Change in Net Operating Assets | -185.35% | -270.98% | 44.22% | 230.72% | -76.67% |
Cash from Operations | -87.92% | -162.82% | 66.74% | 366.15% | -15.83% |
Capital Expenditure | -43.32% | 58.43% | -219.32% | -64.20% | -12.15% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 575.29% | -5.35% | -101.35% | 41.55% | -91.99% |
Cash from Investing | 617.92% | -2.78% | -101.72% | 40.28% | -92.55% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 2,956.52% | -- | 65,800.00% | 609.68% | -91.48% |
Repurchase of Common Stock | -163.14% | -851.35% | -722.25% | -145.04% | -671.70% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -143.04% | -844.95% | -643.46% | -137.70% | -2,073.47% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -28.61% | -223.12% | 46.70% | 180.81% | -61.08% |